Rob Rodrigues, attorney at law, had his article “Brazil: Pharmacovigilance Risk in Evolving Biosimilar Regulation” published on the FDLI – Food and Drug Law Institute website. Read it in full at: http://static.lickslegal.com/pdf/FDLI%20-%20Brazil_Pharmacovigilance_Risk_in_Evolvin%202015.pdf
Previous Post
There is no previous post
Back to all postsNext Post
There is no next post
Back to all postsRegister your email and receive our updates